Ofloxacin Tablets

Indications for Ofloxacin Tablets : Susceptible infections including acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, acute pelvic inflammatory disease (PID), acute, uncomplicated cervical and urethral gonorrhea, urethritis, cervicitis, uncomplicated cystitis, uncomplicated skin and skin structure, complicated UTIs, prostatitis.

Adult : ≥18yrs -  Take with full glass water. Bronchitis, pneumonia, uncomplicated skin and skin structure -  400mg every 12 hours for 10 days. Urethritis, cervicitis -  300mg every 12 hours for 7 days. Gonorrhea -  400mg once as a single dose. PID -  400mg every 12 hours for 10–14 days. Uncomplicated cystitis due to E. coli or K. pneumoniae -  200mg every 12 hrs for 3 days. Other uncomplicated cystitis -  200mg every 12 hrs for 7 days. Complicated UTIs -  200mg every 12 hrs for 10 days. Prostatitis due to E. coli -  300mg every 12 hours for 6 weeks. Severe hepatic impairment -  max 400mg/day. Renal impairment -  CrCl 20–50mL/min -  give normal dose (loading dose) and increase dosing interval to 24 hours. CrCl <20mL/min -  give normal dose once (loading dose) then ½ normal dose and increase dosing interval to 24 hours.

Children : <18yrs: not recommended.

Warnings/Precautions :  Increased risk of tendinitis or tendon rupture esp. in patients >60yrs, or those with kidney, heart, or lung transplants. CNS disorders (e.g., cerebral arteriosclerosis, epilepsy) that increase seizure risk. Discontinue if CNS effects, photosensitization, allergic reactions, peripheral neuropathy, or tendon pain, inflammation or rupture occurs. History of QT prolongation or proarrhythmic conditions (eg, hypokalemia, bradycardia, recent MI). May mask symptoms of syphilis; test for syphilis before treating gonorrhea then follow-up after 3 months. Maintain adequate hydration. Avoid excessive sun or UV light. Monitor blood, renal, and hepatic function in prolonged use. Renal or severe hepatic impairment. Pregnancy (Cat.C), nursing mothers: not recommended.

Interactions : Avoid drugs that prolong QTc interval (eg, Class IA or Class III antiarrhythmics, erythromycin, antipsychotics, tricyclics). Separate dosing of magnesium- or aluminum-containing antacids and didanosine, sucralfate, iron, zinc, other metal cations (separate dosing by 2hrs). Increased risk of seizures with NSAIDs. May potentiate cyclosporine, theophylline, warfarin; monitor. May potentiate insulin, oral hypoglycemics (discontinue ofloxacin if hypoglycemia occurs). Increased risk of tendinitis and tendon rupture with corticosteroids. Monitor drugs metabolized by CYP450.

Pharmacological Class : Quinolone.

Adverse Reactions : GI upset, dizziness, rash, pruritus, dysgeusia; CNS stimulation (eg, convulsions, nervousness, anxiety), hypersensitivity reactions, phototoxicity, tendinitis/rupture; rarely: peripheral neuropathy.